Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency and usual COPD Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Variability of sputum inflammatory mediators in alpha-1-antitrypsin deficiency Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010
Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013
Variability of sputum inflammatory mediators in COPD and ?1-antitrypsin deficiency}, Source: Eur Respir J 2012; 40: 561-569 Year: 2012
Inflammatory markers in COPD patients with and without cachexia Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017
Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003
Inflammatory phenotypes of COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015
Inflammatory mediators CRP, fibrinogen and leukocyte in stable COPD patients Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007
Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Inflammatory bowel diseases in COPD patients. Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Inflammatory cytokines of patients with peripheral arterial disease and COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010
Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein Source: International Congress 2016 – Translational studies in lung disease Year: 2016
Functional and inflammatory bowel diseases in patients with COPD Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Leptin and inflammatory cytokines during COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005
Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014